ArcherDX snags $55 mln Series C
Boulder, Colorado-based ArcherDX Inc, a molecular diagnostics company, has secured $55 million in Series C financing.
Boulder, Colorado-based ArcherDX Inc, a molecular diagnostics company, has secured $55 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination